Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction
A precise and accurate high‐performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid‐phase extraction. The method was validated with respect to selectivity, extraction recovery, lin...
Gespeichert in:
| Veröffentlicht in: | Biomedical chromatography 2016-12, Vol.30 (12), p.2009-2015 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2015 |
|---|---|
| container_issue | 12 |
| container_start_page | 2009 |
| container_title | Biomedical chromatography |
| container_volume | 30 |
| creator | Louveau, B. Fernandez, C. Zahr, N. Sauvageon-Martre, H. Maslanka, P. Faure, P. Mourah, S. Goldwirt, L. |
| description | A precise and accurate high‐performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid‐phase extraction. The method was validated with respect to selectivity, extraction recovery, linearity, intra‐ and inter‐day precision, accuracy, lower limit of quantification and stability. Chromatographic separation was performed on a Chromolith RP8 column using a mixture of 0.05 m acetate buffer pH 5.7–acetonitrile (35:65, v/v) as mobile phase. The compounds were detected at a wavelength of 335 nm with a lower limit of quantification of 0.05 mg/L in human plasma. Retention times for rifampicin and 6,7‐dimethyl‐2,3‐di(2‐pyridyl) quinoxaline used as internal standard were respectively 3.77 and 4.81 min. This robust and exact method was successfully applied in routine for therapeutic drug monitoring in patients treated with rifampicin. |
| doi_str_mv | 10.1002/bmc.3778 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1850785001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1850785001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3928-8bf33b30655ff3420c7e15ec11118d5a3b30da23258e3dd09cd6cc633ce213c13</originalsourceid><addsrcrecordid>eNqNkc1u1DAURi0EokOLxBMgL9mk-KeJnSVMoS1qS5FAsLMc-6YxOHFqJ7TD4_CkeNq0rJCwbHlxzz3f4kPoBSX7lBD2uunNPhdCPkIrSuq6IJLQx2hFWFUXXIp6Bz1L6TshpK6YeIp2mGCScCZW6PchTBB7N-jJhQGHFkfX6n50xg04327u9YBHr1OvcbPBnbvsihFiG2IeGMDeXc3OYtPF0OspXEY9dhtswjx6sPjaTR2e_RT1Txc8TNjmOHMbpdscjPU8bffcrwyn4J0tFiHc5KVbcg89abVP8Hz5d9GX9-8-r4-L049HJ-s3p4XhNZOFbFrOG06qsmxbfsCIEUBLMDQfaUu9nVnNOCslcGtJbWxlTMW5AUa5oXwXvbrzjjFczZAm1btkwHs9QJiTorIkIj_yPyirqro8IPIvamJIKUKrxuh6HTeKErUtT-Xy1La8jL5crHPTg30A79vKQHEHXDsPm3-K1Nuz9SJceJcmuHngdfyhKsFFqb6eH6kP4kKK809EfeN_AIiLtm4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826695408</pqid></control><display><type>article</type><title>Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Louveau, B. ; Fernandez, C. ; Zahr, N. ; Sauvageon-Martre, H. ; Maslanka, P. ; Faure, P. ; Mourah, S. ; Goldwirt, L.</creator><creatorcontrib>Louveau, B. ; Fernandez, C. ; Zahr, N. ; Sauvageon-Martre, H. ; Maslanka, P. ; Faure, P. ; Mourah, S. ; Goldwirt, L.</creatorcontrib><description>A precise and accurate high‐performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid‐phase extraction. The method was validated with respect to selectivity, extraction recovery, linearity, intra‐ and inter‐day precision, accuracy, lower limit of quantification and stability. Chromatographic separation was performed on a Chromolith RP8 column using a mixture of 0.05 m acetate buffer pH 5.7–acetonitrile (35:65, v/v) as mobile phase. The compounds were detected at a wavelength of 335 nm with a lower limit of quantification of 0.05 mg/L in human plasma. Retention times for rifampicin and 6,7‐dimethyl‐2,3‐di(2‐pyridyl) quinoxaline used as internal standard were respectively 3.77 and 4.81 min. This robust and exact method was successfully applied in routine for therapeutic drug monitoring in patients treated with rifampicin.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.3778</identifier><identifier>PMID: 27280327</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - isolation & purification ; Anti-Bacterial Agents - pharmacokinetics ; Automation ; automatized solid-liquid extraction ; Chromatography, High Pressure Liquid - methods ; cost-effective ; HPLC-UV ; Humans ; Limit of Detection ; Reference Standards ; Reproducibility of Results ; rifampicin ; Rifampin - blood ; Rifampin - isolation & purification ; Rifampin - pharmacokinetics ; Spectrophotometry, Ultraviolet - methods ; therapeutic drug monitoring ; time-effective</subject><ispartof>Biomedical chromatography, 2016-12, Vol.30 (12), p.2009-2015</ispartof><rights>Copyright © 2016 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3928-8bf33b30655ff3420c7e15ec11118d5a3b30da23258e3dd09cd6cc633ce213c13</citedby><cites>FETCH-LOGICAL-c3928-8bf33b30655ff3420c7e15ec11118d5a3b30da23258e3dd09cd6cc633ce213c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.3778$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.3778$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27926,27927,45576,45577</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27280327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Louveau, B.</creatorcontrib><creatorcontrib>Fernandez, C.</creatorcontrib><creatorcontrib>Zahr, N.</creatorcontrib><creatorcontrib>Sauvageon-Martre, H.</creatorcontrib><creatorcontrib>Maslanka, P.</creatorcontrib><creatorcontrib>Faure, P.</creatorcontrib><creatorcontrib>Mourah, S.</creatorcontrib><creatorcontrib>Goldwirt, L.</creatorcontrib><title>Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction</title><title>Biomedical chromatography</title><addtitle>Biomedical Chromatography</addtitle><description>A precise and accurate high‐performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid‐phase extraction. The method was validated with respect to selectivity, extraction recovery, linearity, intra‐ and inter‐day precision, accuracy, lower limit of quantification and stability. Chromatographic separation was performed on a Chromolith RP8 column using a mixture of 0.05 m acetate buffer pH 5.7–acetonitrile (35:65, v/v) as mobile phase. The compounds were detected at a wavelength of 335 nm with a lower limit of quantification of 0.05 mg/L in human plasma. Retention times for rifampicin and 6,7‐dimethyl‐2,3‐di(2‐pyridyl) quinoxaline used as internal standard were respectively 3.77 and 4.81 min. This robust and exact method was successfully applied in routine for therapeutic drug monitoring in patients treated with rifampicin.</description><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - isolation & purification</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Automation</subject><subject>automatized solid-liquid extraction</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>cost-effective</subject><subject>HPLC-UV</subject><subject>Humans</subject><subject>Limit of Detection</subject><subject>Reference Standards</subject><subject>Reproducibility of Results</subject><subject>rifampicin</subject><subject>Rifampin - blood</subject><subject>Rifampin - isolation & purification</subject><subject>Rifampin - pharmacokinetics</subject><subject>Spectrophotometry, Ultraviolet - methods</subject><subject>therapeutic drug monitoring</subject><subject>time-effective</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAURi0EokOLxBMgL9mk-KeJnSVMoS1qS5FAsLMc-6YxOHFqJ7TD4_CkeNq0rJCwbHlxzz3f4kPoBSX7lBD2uunNPhdCPkIrSuq6IJLQx2hFWFUXXIp6Bz1L6TshpK6YeIp2mGCScCZW6PchTBB7N-jJhQGHFkfX6n50xg04327u9YBHr1OvcbPBnbvsihFiG2IeGMDeXc3OYtPF0OspXEY9dhtswjx6sPjaTR2e_RT1Txc8TNjmOHMbpdscjPU8bffcrwyn4J0tFiHc5KVbcg89abVP8Hz5d9GX9-8-r4-L049HJ-s3p4XhNZOFbFrOG06qsmxbfsCIEUBLMDQfaUu9nVnNOCslcGtJbWxlTMW5AUa5oXwXvbrzjjFczZAm1btkwHs9QJiTorIkIj_yPyirqro8IPIvamJIKUKrxuh6HTeKErUtT-Xy1La8jL5crHPTg30A79vKQHEHXDsPm3-K1Nuz9SJceJcmuHngdfyhKsFFqb6eH6kP4kKK809EfeN_AIiLtm4</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Louveau, B.</creator><creator>Fernandez, C.</creator><creator>Zahr, N.</creator><creator>Sauvageon-Martre, H.</creator><creator>Maslanka, P.</creator><creator>Faure, P.</creator><creator>Mourah, S.</creator><creator>Goldwirt, L.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201612</creationdate><title>Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction</title><author>Louveau, B. ; Fernandez, C. ; Zahr, N. ; Sauvageon-Martre, H. ; Maslanka, P. ; Faure, P. ; Mourah, S. ; Goldwirt, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3928-8bf33b30655ff3420c7e15ec11118d5a3b30da23258e3dd09cd6cc633ce213c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - isolation & purification</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Automation</topic><topic>automatized solid-liquid extraction</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>cost-effective</topic><topic>HPLC-UV</topic><topic>Humans</topic><topic>Limit of Detection</topic><topic>Reference Standards</topic><topic>Reproducibility of Results</topic><topic>rifampicin</topic><topic>Rifampin - blood</topic><topic>Rifampin - isolation & purification</topic><topic>Rifampin - pharmacokinetics</topic><topic>Spectrophotometry, Ultraviolet - methods</topic><topic>therapeutic drug monitoring</topic><topic>time-effective</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louveau, B.</creatorcontrib><creatorcontrib>Fernandez, C.</creatorcontrib><creatorcontrib>Zahr, N.</creatorcontrib><creatorcontrib>Sauvageon-Martre, H.</creatorcontrib><creatorcontrib>Maslanka, P.</creatorcontrib><creatorcontrib>Faure, P.</creatorcontrib><creatorcontrib>Mourah, S.</creatorcontrib><creatorcontrib>Goldwirt, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louveau, B.</au><au>Fernandez, C.</au><au>Zahr, N.</au><au>Sauvageon-Martre, H.</au><au>Maslanka, P.</au><au>Faure, P.</au><au>Mourah, S.</au><au>Goldwirt, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomedical Chromatography</addtitle><date>2016-12</date><risdate>2016</risdate><volume>30</volume><issue>12</issue><spage>2009</spage><epage>2015</epage><pages>2009-2015</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>A precise and accurate high‐performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid‐phase extraction. The method was validated with respect to selectivity, extraction recovery, linearity, intra‐ and inter‐day precision, accuracy, lower limit of quantification and stability. Chromatographic separation was performed on a Chromolith RP8 column using a mixture of 0.05 m acetate buffer pH 5.7–acetonitrile (35:65, v/v) as mobile phase. The compounds were detected at a wavelength of 335 nm with a lower limit of quantification of 0.05 mg/L in human plasma. Retention times for rifampicin and 6,7‐dimethyl‐2,3‐di(2‐pyridyl) quinoxaline used as internal standard were respectively 3.77 and 4.81 min. This robust and exact method was successfully applied in routine for therapeutic drug monitoring in patients treated with rifampicin.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>27280327</pmid><doi>10.1002/bmc.3778</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-3879 |
| ispartof | Biomedical chromatography, 2016-12, Vol.30 (12), p.2009-2015 |
| issn | 0269-3879 1099-0801 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1850785001 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Anti-Bacterial Agents - blood Anti-Bacterial Agents - isolation & purification Anti-Bacterial Agents - pharmacokinetics Automation automatized solid-liquid extraction Chromatography, High Pressure Liquid - methods cost-effective HPLC-UV Humans Limit of Detection Reference Standards Reproducibility of Results rifampicin Rifampin - blood Rifampin - isolation & purification Rifampin - pharmacokinetics Spectrophotometry, Ultraviolet - methods therapeutic drug monitoring time-effective |
| title | Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20rifampicin%20in%20human%20plasma%20by%20high-performance%20liquid%20chromatography%20coupled%20with%20ultraviolet%20detection%20after%20automatized%20solid-liquid%20extraction&rft.jtitle=Biomedical%20chromatography&rft.au=Louveau,%20B.&rft.date=2016-12&rft.volume=30&rft.issue=12&rft.spage=2009&rft.epage=2015&rft.pages=2009-2015&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.3778&rft_dat=%3Cproquest_cross%3E1850785001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826695408&rft_id=info:pmid/27280327&rfr_iscdi=true |